BLMH.c makes strategic expansion for continued growth. Bloom Health Partners’ (CSE: BLMH) recent expansion into Hawaii all but confirms the company will surpass its Fiscal 2022 yearly guidance.
This new market is untapped by BLMH, and the new location provides expanded laboratories for operational health services and diagnostic testing to meet continued demand. The Honolulu location will serve film/TV productions in addition to new opportunities with local businesses and organizations in the surrounding area.
BLMH has already met its lower range yearly guidance of $25M, and with no indication the company will fall short of its quarterly earnings YTD, revenues should easily surpass the upper threshold of $28M by year end. I expect Q4 revenue will bring the company’s yearly earnings to well over $30M.
BLMH.c is currently trading at $.19, valued at $9.06 million.
https://ceo.ca/@newsfile/bloom-health-partners-announces-new-location-in-hawaii